Hepatocellular carcinoma: Therapeutic guidelines and medical treatment Journal Article
| Authors: | Kudo, M.; Trevisani, F.; Abou-Alfa, G. K.; Rimassa, L. |
| Article Title: | Hepatocellular carcinoma: Therapeutic guidelines and medical treatment |
| Abstract: | Western and Eastern perspectives on therapeutic guidelines for hepatocellular carcinoma (HCC) have many commonalities but may also differ in certain aspects, as described in this article. In view of the limited therapeutic options for advanced HCC, evidence-based therapies are few, and thus there is a dependence on consensus-based guidelines. This article focuses on the Italian Association for the Study of the Liver guidelines and the Japanese approaches to therapy, while drawing attention to certain controversies from other academic bodies where applicable and appropriate. Copyright (C) 2016 S. Karger AG, Basel |
| Keywords: | hepatocellular carcinoma; sorafenib; treatment; practice guideline; algorithm; surgical resection; management; trial; phase-iii; ablation; 2nd-line treatment; adult patients; clinical-practice guidelines; tivantinib; japanese nationwide survey |
| Journal Title: | Liver Cancer |
| Volume: | 6 |
| Issue: | 1 |
| ISSN: | 2235-1795 |
| Publisher: | Karger |
| Date Published: | 2017-01-01 |
| Start Page: | 16 |
| End Page: | 26 |
| Language: | English |
| ACCESSION: | WOS:000394192100003 |
| DOI: | 10.1159/000449343 |
| PROVIDER: | wos |
| PMCID: | PMC5159738 |
| PUBMED: | 27995084 |
| Notes: | Article; Proceedings Paper -- 1st Meeting of the Eastern-and-Western-Association-for-the-Study-of-Liver-Tumors -- 2015 -- Milan, ITALY -- Source: Wos |
